Relazione su terapia farmacologica antiaritmica della fibrillazione atriale, dalla terapia classica a quella del futuro, passando per l’upstream therapy
Relazione su terapia farmacologica antiaritmica della fibrillazione atriale, dalla terapia classica a quella del futuro, passando per l’upstream therapy
Created using ChatSlide
This document outlines the clinical objectives and boundaries of pharmacological management in atrial fibrillation (AF), emphasizing symptom reduction, integration of treatment strategies, and patient preferences. It discusses the transition from clinical trials to practical endpoints, focusing on relevant clinical outcomes and the importance of assessing atrial substrate and comorbidities before antiarrhythmic therapy. The strategy for rhythm control, the efficacy of Class I and III drugs,...